Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;26(3):266-268.
doi: 10.1007/s11102-023-01324-5. Epub 2023 Jun 15.

Refractory somatotroph adenomas

Affiliations
Review

Refractory somatotroph adenomas

Monica R Gadelha et al. Pituitary. 2023 Jun.

Abstract

Somatotroph adenomas are usually controlled with standard therapy, which can include surgery, medical treatment and radiotherapy. Some tumors have a more aggressive behavior and are refractory to standard therapy. In this review, we summarize the phenotype of these tumors and the current options for their management.

Keywords: Acromegaly; Aggressive adenomas; Pasireotide; Pegvisomant; Somatostatin receptor ligands.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM, Endocrinology E, S.o (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1–G24 - DOI - PubMed
    1. Liu X, Dai C, Feng M, Li M, Chen G, Wang R (2021) Diagnosis and treatment of refractory pituitary adenomas: a narrative review. Gland Surg 10:1499–1507 - DOI - PubMed - PMC
    1. Conficoni A, Feraco P, Mazzatenta D, Zoli M, Asioli S, Zenesini C, Fabbri VP, Cellerini M, Bacci A (2020) Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study. Br J Radiol 93:20200321 - DOI - PubMed - PMC
    1. Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM, Camacho AHS, Chimelli L, Niemeyer P, Gadelha MR, Kasuki L (2018) Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60:415–422 - DOI - PubMed
    1. Gadelha MR, Kasuki L, Korbonits M (2013) Novel pathway for somatostatin analogs in patients with acromegaly. Trends Endocrinol Metab 24:238–246 - DOI - PubMed

LinkOut - more resources